AI Development for Healthcare Organizations

ZTABS builds custom AI systems for healthcare organizations that need production-grade models under real regulatory scrutiny. We work with health systems, digital health startups, pharma companies and payer organizations on clinical decision support, medical NLP, patient risk stratification and revenue cycle automation.

The global AI in healthcare market reached $36.7 billion in 2025, with North America holding 54% of revenue. It is projected to grow to $50.7 billion in 2026 and reach $505.6 billion by 2033 at a 38.9% CAGR (Grand View Research). U.S. healthcare AI spending hit $1.4 billion in 2025, nearly tripling 2024 investment. Health systems supplied $1 billion of that total, led by ambient clinical documentation ($600 million) and coding and billing automation ($450 million). Twenty-two percent of healthcare organizations have now implemented domain-specific AI tools, a 7x increase over 2024 (Menlo Ventures 2025 State of AI in Healthcare).

Healthcare AI is not a general-purpose technology problem. Every model touches protected health information, every prediction influences a clinical decision, and every integration must pass compliance review. Our broader AI capabilities are on the AI development services page.

Healthcare AI projects at a glance

Why healthcare AI projects fail

Most healthcare AI projects that stall do not fail on the model. They fail on integration, compliance, or workflow fit.

The first failure point is data access. Getting de-identified training data from an EHR takes weeks or months, and the de-identification itself is technically challenging. Clinical notes contain PHI in narrative form: patient names in discharge summaries, addresses in social history, family member names in family history. Rule-based de-identification catches structured fields (MRN, DOB, phone numbers), but unstructured text requires transformer-based models trained on clinical language patterns.

The second failure point is EHR integration. A model that produces accurate predictions is useless if it cannot surface those predictions at the right point in the clinical workflow. A readmission risk score delivered as a batch report three days after discharge is too late. It needs to fire as a CDS Hooks service within the discharge navigator, at the moment the care team is making the discharge plan.

The third failure point is clinician trust. Physicians will not act on a model they do not understand. Every deployment needs clear documentation of what the model considers, what it does not consider, and where it has been validated. Black-box predictions are not acceptable in clinical settings.

How we build healthcare AI

Compliance-first architecture

Before we write model code, we map the data flow: where PHI enters the system, how it moves between services, where it gets stored, and who has access at each stage. This map becomes the foundation for the BAA, the security controls, and the deployment architecture.

De-identification and training

We build de-identification pipelines using rule-based NER for structured fields and transformer-based models for unstructured clinical text. De-identified data goes through re-identification risk assessment before training begins. We also generate synthetic patient data for early development phases, introducing de-identified real data only after the pipeline is verified.

EHR integration

We build FHIR-native APIs that slot into existing workflows. For Epic, we handle App Orchard certification, SMART on FHIR launch contexts, and Epic-specific authentication flows. For clinical decision support, we build CDS Hooks-compliant services that fire at the right workflow points without creating alert fatigue.

Deployment and monitoring

For health systems with on-premise requirements, we deploy containerized inference services within their existing infrastructure, using their identity provider and logging systems. For cloud-native organizations, we deploy on HIPAA-eligible services (AWS GovCloud, Azure Healthcare APIs, or Google Cloud Healthcare API) with encryption, VPC isolation, and automated compliance monitoring.

Every deployment includes automated model monitoring: distribution drift detection using KL divergence and population stability index, bias auditing across demographic groups (age, sex, race, insurance type), and versioned model registries with complete audit trails.

Healthcare data formats we work with

Healthcare data is not CSV files. Each data type has its own standard, and getting the data pipeline right is often the hardest engineering work in a healthcare AI project.

The ONC Cures Act requires FHIR-based interoperability (ONC Final Rule), which means new integration work should be FHIR-native. Legacy integrations still use HL7 v2 messaging, and we handle both.

Cost and timeline

Healthcare AI costs depend on model complexity, EHR integration depth, and compliance requirements. These ranges draw from our published guides for AI agents, RAG systems, and AI chatbots.

All engagements include BAA execution, HIPAA compliance documentation, de-identification pipeline development, and 90 days of post-deployment model monitoring. FDA SaMD documentation adds $15K to $40K depending on the regulatory pathway.

Choosing a healthcare AI partner

ZTABS AI/ML engineers run $60 to $120/hr. Unlike SaaS vendors, we give you full ownership of the model, the training pipeline and the deployment infrastructure, with no per-prediction licensing fees.

Ask each vendor three questions. First, can you describe the de-identification pipeline you would use for our clinical notes? Second, how does the model integrate into our EHR's clinical workflow (not just the data warehouse)? Third, who owns the model, training pipeline, and deployment infrastructure after the engagement ends?

When ZTABS is not the right fit

• You need a team embedded in your hospital daily. We are remote-first by design and work via video sessions. If your project requires daily bedside presence, a local health IT consultancy may be a better fit.
• You need an FDA regulatory affairs lead. We support the technical documentation, but a regulatory affairs specialist should own the FDA submission strategy.
• Your project requires prospective clinical trials. We build and validate software, but clinical trial design and IRB oversight require clinical research expertise.
• An off-the-shelf product covers your use case. If a SaaS vendor's existing model fits your workflow and data, buying it is faster and cheaper than a custom build.
• Your data infrastructure is not ready. If you cannot extract de-identified training data from your EHR within a reasonable timeframe, the project will stall regardless of who builds the model.

Risks that delay healthcare AI projects

The same problems account for most delays in clinical AI engagements. Each is avoidable with early planning.

• Data access takes months, not weeks. Getting de-identified training data from an EHR requires IRB approval (or IRB exemption determination), data use agreements, IT security review and extraction scripting. At large health systems, this process routinely takes 3 to 6 months. We start with synthetic patient data for architecture validation and model prototyping while the real data pipeline is being approved, so engineering work is never blocked waiting on data access.
• De-identification is harder than expected. Structured fields (MRN, DOB, phone numbers) are straightforward to redact. Unstructured clinical notes are not. Physician notes contain patient names in narrative, addresses in social history, family member names in family history, and employer names in occupational history. Rule-based NER catches common patterns, but transformer-based models trained on clinical language are needed for reliable de-identification of free text. We build and validate the de-identification pipeline before any model training begins.
• Alert fatigue kills adoption. A model that fires too many alerts trains clinicians to ignore it. If 90% of alerts are false positives, physicians will override the system by default and the investment is wasted. We tune alert thresholds using precision-recall tradeoffs specific to the clinical workflow and implement tiered alerting (informational, advisory, critical) so only high-confidence predictions interrupt the clinician's workflow.
• Bias in training data creates liability. Historical clinical data reflects historical care patterns, including disparities. A readmission model trained predominantly on one demographic may underperform on others. We audit model performance across age, sex, race and insurance type before deployment, and we build ongoing demographic monitoring into the production system so performance gaps are caught early.
• EHR vendor timelines are unpredictable. Epic App Orchard certification, Oracle Health marketplace review and other EHR vendor processes operate on their own timelines. A 4-week review can stretch to 12 weeks. We start the vendor certification process early and build the integration against sandbox environments so the model is ready before certification completes.
• Model drift goes undetected without monitoring. Clinical AI models degrade over time as patient populations shift, treatment protocols change, and coding practices evolve. A sepsis prediction model trained on pre-COVID data may perform differently on current patient populations. We deploy automated drift detection that compares live prediction distributions against validation baselines and triggers retraining workflows when performance degrades beyond configurable thresholds. Monthly performance reports go to both the clinical and technical teams so degradation is caught before it affects patient care.

Questions to ask any healthcare AI development partner

1. Walk me through how you would de-identify our clinical notes. Look for specific answers about structured vs. unstructured data handling, NER models trained on clinical text, and validation against re-identification risk. Generic answers about "removing PII" are insufficient for clinical free text where patient names appear in narrative.
2. How does your model integrate into the clinical workflow, not just the data warehouse? A model that requires clinicians to open a separate application will not get used. Ask how the model surfaces predictions inside the EHR at the point of care, whether that is an Epic BPA, an Oracle Health alert, or a SMART on FHIR panel.
3. How do you handle model performance disparities across patient demographics? The vendor should describe specific fairness metrics (equalized odds, calibration across subgroups) and ongoing demographic monitoring. If they have not encountered this issue, they have not deployed clinical models at scale.
4. Who owns the model, training pipeline and deployment infrastructure after the engagement? Healthcare organizations should own their AI assets. Ask explicitly about IP ownership, source code access, and whether the vendor's platform is required for ongoing model operation.